Inactive Instrument
Global Blood Therapeutics, Inc. Stock
Stocks
GBT
US37890U1088
Biotechnology & Medical Research
| 1 day | +0.01% |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 05/10/22 | Issuer sale | Chief Financial Officer | 448,218 | 0.6643% | ||
| 05/10/22 | Issuer sale | Director | 29,709 | 0.0440% | ||
| 05/10/22 | Issuer sale | Director | 81,659 | 0.1210% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.01% | +0.56% | - | - | 4.62B | |
| +0.34% | +1.09% | -10.67% | -5.05% | 43.13B | |
| +1.73% | +3.59% | +318.08% | +564.04% | 34.65B | |
| +0.61% | +1.34% | +10.00% | +46.20% | 30.03B | |
| +0.02% | -5.93% | +8.45% | -21.44% | 28B | |
| -1.06% | -2.60% | +9.08% | +21.51% | 24.45B | |
| -1.23% | +2.11% | - | - | 14.34B | |
| -0.99% | -2.53% | +47.29% | +102.88% | 13.14B | |
| +1.54% | +0.16% | +6.69% | +8.89% | 12.53B | |
| +2.39% | +2.61% | +102.86% | +84.20% | 12.25B | |
| Average | +0.34% | -0.49% | +61.47% | +100.15% | 23.61B | |
| Weighted average by Cap. | +0.39% | -0.25% | +67.04% | +116.73% |
Employees
457
